New Jersey says 3 chemical makers agree to 'forever chemical' settlement worth up to $2 billion

DuPont, Chemours, and Corteva have agreed to pay New Jersey up to $2 billion to settle environmental claims related to PFAS "forever chemicals," marking the state's largest such settlement. The agreement includes an $875 million payment over 25 years and a $1.2 billion remediation fund, resolving all pending legacy contamination claims at four sites. This follows a recent $450 million PFAS settlement by 3M, underscoring growing regulatory and financial liabilities for chemical manufacturers facing widespread environmental contamination issues.

Analysis

DuPont (DD), Chemours (CC), and Corteva (CTVA) have reached a significant settlement with the state of New Jersey, agreeing to pay up to $2 billion to resolve environmental claims related to PFAS chemical contamination. This agreement, the largest in the state's history, is structured with an $875 million payment spread over 25 years and a remediation fund of up to $1.2 billion, with the costs to be split among the three companies. The settlement is notable not only for its size but also for its timing, coming just months after 3M's separate $450 million PFAS settlement with New Jersey, indicating an intensifying regulatory and legal environment for chemical manufacturers. While the deal resolves all pending legacy claims at four specific sites, providing a degree of certainty and removing a major financial overhang for those locations, the highly negative per-ticker sentiment of -0.7 for each of the settling companies reflects the material financial impact. This event underscores the materialization of ESG risks, as states become more aggressive in holding companies accountable for historical pollution, a trend that is unlikely to be confined to New Jersey.

Key Decisions for Investors

• Investors in DuPont, Chemours, and Corteva should weigh the immediate financial impact of this large settlement against the long-term benefit of resolving a significant legal uncertainty in a key jurisdiction.
• This settlement establishes a costly precedent for PFAS litigation; therefore, investors in the broader chemical sector must re-evaluate and price in heightened legal and financial risks for any company with historical exposure to 'forever chemicals'.
• Given the settlement is limited to four specific New Jersey sites, it is crucial to monitor for further litigation or regulatory actions against these companies in other states, as this does not represent a global resolution of their PFAS liabilities.
• The aggressive enforcement action highlights tangible ESG risks, prompting investors with ESG mandates to scrutinize their holdings in chemical companies and assess the adequacy of provisions for environmental liabilities on their balance sheets.